Axinn Retains Top Rankings in LMG Life Sciences 2025
October 3, 2025
Axinn is pleased to announce that LMG Life Sciences has once again recognized the firm and its attorneys among the industry’s leaders for 2025. Partners Matt Becker and Aziz Burgy were named Life Sciences Stars, highlighting their continued excellence and impact in the field. Associate Ricardo Camposanto also retained his Rising Star designation, affirming his status as one of the industry’s emerging leaders.
This year, LMG Life Sciences ranked Axinn in Tier 2 for Hatch-Waxman Patent Litigation (Generic), underscoring the firm’s strength and experience in handling complex pharmaceutical patent cases.
LMG Life Sciences is the only legal ranking directory dedicated to identifying the top firms and lawyers across the life sciences sector.
About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth, always thinking ahead.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust